Viatris Inc.

Healthcare

NASDAQ:VTRS · NASDAQ Global Select

Market Cap $19.19B Beta 0.90 P/E (TTM) -64.2

$16.48 +1.04%

+$0.17 today

52W Low $8.63High $17.53

Vol 6.16M · Avg 10.75M

EPS (TTM)-$0.26

Div Yield2.91%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+91.85%

Period High

$17.26

Period Low

$8.41

Latest

$16.48

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Roivant Sciences Ltd.

NASDAQ:ROIV

$21.61B

Exact Sciences Corporation

EXAS

$20.03B

Moderna, Inc.

NASDAQ:MRNA

$19.80B

Neurocrine Biosciences, Inc.

NASDAQ:NBIX

$16.06B

BridgeBio Pharma, Inc.

NASDAQ:BBIO

$13.08B

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

$12.11B

Elanco Animal Health Incorporated

NYSE:ELAN

$12.07B

Dr. Reddy's Laboratories Limited

NYSE:RDY

$11.07B

Baxter International Inc.

NYSE:BAX

$10.77B

Regencell Bioscience Holdings Limited

NASDAQ:RGC

$9.31B

What is the latest VTRS filing?

The latest filing shown is 424B5 dated Jun 12, 2026.

How many recent filings does VTRS have?

Intrinsic Alpha currently shows 20 recent filings for VTRS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.